A stepwise regression analysis in a group of 57 cognitively intact individuals between 60 and 92 years of age from the Berkeley Aging Cohort study yielded entorhinal tau PET tracer retention as the most significant predictor for subsequent cognitive decline [12], even in amyloid-negative individuals. This evidence concerns the gene MAPT and Mental deterioration.